Vitamin D and health in pregnancy, infants, children and adolescents in Australia and New Zealand: a position statement.

Paxton, G. A., Teale, G. R., Nowson, C. A., Mason, R. S., McGrath, J. J., Thompson, M. J., Siafarikas, A., Rodda, C. P. and Munns, C. F. 2013, Vitamin D and health in pregnancy, infants, children and adolescents in Australia and New Zealand: a position statement., Medical journal of Australia, vol. 198, no. 3, pp. 1-8.

Attached Files
Name Description MIMEType Size Downloads

Title Vitamin D and health in pregnancy, infants, children and adolescents in Australia and New Zealand: a position statement.
Author(s) Paxton, G. A.
Teale, G. R.
Nowson, C. A.
Mason, R. S.
McGrath, J. J.
Thompson, M. J.
Siafarikas, A.
Rodda, C. P.
Munns, C. F.
Journal name Medical journal of Australia
Volume number 198
Issue number 3
Start page 1
End page 8
Total pages 8
Publisher Australasian Medical Publishing Company
Place of publication Sydney, N.S.W.
Publication date 2013-02-18
ISSN 0025-729X
1326-5377
Keyword(s) nutrition
public health
vitamin D
pregnancy
infants
children
adolescents
Summary The recommended level for serum 25-hydroxyvitamin D (25(OH)D) in infants,  children,  dolescents and during pregnancy and lactation is ≥ 50 nmol/L. This level may need to be 10-20 nmol/L higher at the end of summer to maintain levels ≥ 50 nmol/L over winter and spring. • Sunlight is the most important source of vitamin D. The US recommended dietary allowance for vitamin D is 600 IU daily in children aged over 12 months and during pregnancy and lactation, assuming minimal sun exposure. • Risk factors for low vitamin D are: lack of skin exposure to sunlight, dark skin, southerly latitude, conditions affecting vitamin D metabolism and storage (including obesity) and, for infants, being born to a mother with low vitamin D and exclusive breastfeeding combined with at least one other risk factor. • Targeted measurement of 25(OH)D levels is recommended for infants, children and adolescents with at least one risk factor for low vitamin D and for pregnant women with at least one risk factor for low vitamin D at the first antenatal visit. • Vitamin D deficiency can be treated with daily low-dose vitamin D supplements, although barriers to adherence have been identified. High-dose intermittent vitamin D can be used in children and adolescents. Treatment should be paired with health education and advice about sensible sun exposure. Infants at risk of low vitamin D should be supplemented with 400 IU vitamin D₃ daily for at least the first year of life. • There is increasing evidence of an association between low vitamin D and a range of non-bone health outcomes, however there is a lack of data from robust randomised controlled trials of vitamin D supplementation.
Language eng
Field of Research 111101 Clinical and Sports Nutrition
Socio Economic Objective 920411 Nutrition
HERDC Research category C1 Refereed article in a scholarly journal
Copyright notice ©2013, Australasian Medical Publishing Co
Persistent URL http://hdl.handle.net/10536/DRO/DU:30053427

Connect to link resolver
 
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.

Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 11 times in TR Web of Science
Scopus Citation Count Cited 1 times in Scopus
Google Scholar Search Google Scholar
Access Statistics: 54 Abstract Views, 6 File Downloads  -  Detailed Statistics
Created: Wed, 03 Jul 2013, 16:55:05 EST by Stella O'connell

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.